C.R. Bard gains clearance for biliary stent

Article

Interventional equipment vendor C.R. Bard received 510(k) clearance this month from the Food and Drug Administration for its Memotherm Flexx biliary stent. The stent is used for treating malignant biliary obstructions, and will be marketed through Murray

Interventional equipment vendor C.R. Bard received 510(k) clearance this month from the Food and Drug Administration for its Memotherm Flexx biliary stent. The stent is used for treating malignant biliary obstructions, and will be marketed through Murray Hill, NJ-based Bard’s peripheral technologies division. The stent is available in diameters from 6 to 12 mm and lengths of 20 to 120 mm.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.